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INTRODUCTION
 
Neoplasm of salivary glands are challenging because of their relative infrequency, 
inconsistent classification and highly variable biologic behaviour.
These  factors  present  some  difficulty  when  attempting  to  compose  data  from 
various institutions describing their experience with salivary gland tumours. 
The salivary gland tumours are relatively rare and constitute 3-4% of all head and 
neck neoplasms.  The majority (70%) of all salivary gland tumours are in the parotid 
gland. Of these, three fourths are benign.
In this study, sincere effort is made to analyse parotid tumours during the years 
May 2006 to November 2008 in our institution. The use of FNAC as a pre-operative 
investigation tool in the management of benign and malignant parotid tumours is also 
analysed   with the help of statistics and comparing them with the literature.
HISTORICAL REVIEW
Previously known as “Para auricular swellings” by Greeks.  In the middle of 
17th century,  the  anatomy  of  the  parotid  gland  and  role  of  the  parotid  ducts  were 
appreciated.
NIELS STENSEN in 1660 identified the parotid duct during the dissection of a 
sheep’s head, but he never knew of the relationship between the duct and the gland.
The  medial  prolongation  of  the  parotid  was  noticed  by  THOREK  (1962).  Its 
development  from ectodermal  origin and from buccal  epithelium was discovered by 
MOOR (1974).  Opening of the parotid duct in the vestibule of the mouth was noticed 
by HAINS and MOHIUDDIN (1972).  The capsule of the parotid gland was described 
by CONLEY (1975).
While  SANCHEZ (1960)  described the  attachment  of  capsule  to  zygomaticarch  and 
stylomandibular ligament.
The  innervation  of  the  parotid  gland  was  discovered  by  various  methods  by 
REIHIERT (1934), KUNTZ (1946), and GENS–GALVEZ (1966). LANGMAN (1976) 
mentioned that the glossopharyngeal nerve, which is the nerve of the third arch, supplies 
the parotid gland. SHELL described the pterygoid process of the gland.
DUPLIESSIS (1975) said that the gland has superficial and sub-facial planes and 
stated that enucleation of the gland was possible without damaging the facial nerve.
          Between 1650 and 1750, salivary gland surgery was limited to the treatment of 
ranulas and ductal calculi.
The concept  of  parotidectomy for  the treatment  of  parotid  tumour  was attributed  to 
BETRANDI (1802).  Initially surgeons were concerned primarily about hemorrhage and 
patients had to leave behind with major disfiguration if they were fortunate enough to 
survive a parotid resection.  The first operation to employ ether inhalation was a parotid 
tumour resection performed by Dr.JOHN.C.WARREN in BOSTON in 1846.
The first total parotidectomy (facial nerve preservation) was done by CODREANU, a 
Romanian in 1892. BLAIR and SISTRUNK systematized the surgical approach to facial 
nerve.  First facial nerve grafting was done early in 1990s.
REVIEW OF THE LITERATURE
Surgical Anatomy
The paired parotid gland are the largest of the salivary glands, each weigh about 
25g  and  is  an  irregular,  lobulated  yellowish  mass,  lying  largely  below the  external 
acoustic  meatus  between  the  mandible  and  the  sternocleidomastoid.  It  also  projects 
forwards on the surface of the masseter, where a small, detached part lies between the 
zygomatic  arch  above  and  the  parotid  duct  below,  the  pars  accessoria  (or)  social 
parotids.
The glandular capsule is derived from the deep cervical fascia. Its superficial layer 
is dense, closely adherent to the gland and attached to the zygomatic arch; medial to the 
gland, it is attached to the styloid process, mandible and tympanic plate blending with 
the fibrous sheaths of related muscles, the fascia extending from the styloid process to 
the mandibular  angle  to  form the stylomandibular  ligament  between the parotid and 
submandibular gland.
The superficial  surface  of  the  gland is  triangular  in  shape,  with  apex pouting 
inferiorly.  The deep surface of the gland is wedged into the parotid space.
PAROTID SPACE:
The parotid space has a skeletal back- ground created.
Anteriorly:   By the ramus of the mandible
Medially:   By the styloid process
Posteriorly:   By the mastoid process 
Postero superiorly: By the external acoustic meatus and the temporo mandibular joint.
The  muscles  that  are  attached  to  these  bony  landmarks  create  the  soft  tissue 
background.
LOBES
The parotid gland is somewhat artificially divided into two lobes by the facial 
nerve.
1. Endo facial (deep)
2. Exo facial (superficial).
There  are  however  multiple  communications  between  the  lobes,  created  by 
bridges of glandular tissue.  A large area of communication referred to as isthmus, is 
related to the proximal part of the interior parotid portion of the facial nerve. 
Approximately 10% of the gland extends medially through the stylomandibular 
tunnel, which is formed ventrally by the posterior edge of the mandibular rami, dorsally 
by the anterior border of the sternocleidomastoid muscle and the posterior belly of the 
digastric muscle, and more deeply and dorsally by the stylomandibular ligament, which 
separates the parotid gland from the submandibular gland.
The  deep  portion  of  the  gland  lies  in  the  pre-styloid  compartment  of  the 
Parapharyngeal  space,  being  anterior  to  the  styloid  process  and its  musculature,  the 
carotid sheath and the cranial nerves IX-XII.  Because the deep lobe of the parotid is 
close to lateral pharyngeal wall, an enlarged deep lobe (or) a dumb – bell tumour will 
push the tonsillar fossa and soft palate intra orally to the opposite side. 
Five processes of the parotid gland have been described. They are the superficial 
three namely condylar,  meatal  and posterior  and deep consisting of  the glenoid and 
stylomandibular.  Because of these extensions and that the facial nerve courses through 
the substance of the nerve, it is nearly impossible to remove all parotid tissue when a 
total parotidectomy is performed.  
The parotid duct courses anteriorly on the lateral surface of the masseter muscle 
and buccal pad of fat and then turns medially almost at right angles goes through the 
buccinator at the level of the upper second molar. The parotid duct during its course may 
receive the duct of the accessory parotid gland. (Fig.1)
NEURO VASCULAR ANATOMY 
The greater auricular nerve is the first neural structure to be encountered when the 
skin-flaps are raised.  The nerve is divided into anterior and posterior branches. 
The Auriculotemporal nerve is the other nerve that could be spared during the 
removal of parotid tumours.
The Auriculotemporal nerve, a branch of the fifth cranial nerve, is found at the 
posterior aspect of the gland, coursing superiorly with the superficial temporal artery 
and vein. It is a sensory nerve to the temporal region and carries parasympathetic fibers 
to the parotid gland to form the Otic ganglion.
  
The  veins  traverse  the  middle  portion  of  the  gland deep  to  facial  nerve.  The 
superficial temporal vein unites with the internal maxillary vein to form the posterior 
facial vein, which branches into anterior and posterior divisions. The anterior branch 
joins the anterior  facial  vein to form the common facial  vein,  whereas the posterior 
division unites with the posterior auricular vein to form the external jugular vein. On its 
decent, the external jugular vein is found on the lateral aspect of the sternocleidomastoid 
muscle, anterior to the greater auricular nerve. This anatomic arrangement is often used 
to help locate the proximal portion of the nerve for grafting purposes.
The external carotid artery and its terminal branches, the internal maxillary and 
the superficial temporal arteries, traverse the deep portion of the parotid gland (Fig.2). 
The superficial temporal artery ascends between the mandibular condyle and external 
auditory canal. Precise localization of this artery occurs just at the root of the zygoma 
anterior to the auricle. The internal maxillary artery, which may be encountered during 
total parotidectomy or removal of deep lobe tumours in the para pharyngeal space, is 
found between the mandibular ramus and sphenomandibular ligament, coursing in close 
proximity to the lateral pterygoid muscle and heading towards the pterygopalatine fossa. 
FACIAL NERVE
The facial nerve exits the stylomastoid foramen from its intra temporal course. 
After the stylomastoid foramen, it gives off branches to stylomastoid, posterior belly of 
digastric and posterior auricular muscles before its transition to pes anserinus.  The 
facial nerve enters the parotid gland on its posterior surface prior to the formation of the 
pes anserinus, approximately 1 cm anterior and 2 cms inferior to the tragus.  The 
superior division of the facial nerve follows a slightly curvilinear course (Fig 3a $3b).
The triangular end of the tragus, that is termed as the tragal (Conley’s) pointer, 
has its value in identifying the landmark of facial nerve.  The palpable depression 
between the bony region of the external auditory canal and anterior aspect of mastoid tip 
is termed “The valley of the nerve”. Within this valley, is the tympano mastoid suture 
line, which reliably leads directly to the facial nerve.
The facial nerve, as it enters into the substance of the parotid gland divides into 
the two major trunks, temporofacial and cervicofacial.  DAVIS and others have studied 
six type of branching pattern of these nerves extensively.
Six types of facial nerve branching has been described based on anastomosis of 
individual branches (Fig.4). Type II occurs in 37.5% of cases, and is the commonest 
pattern  seen.   The  temporofacial  consists  of  temporal,  zygomatic,  and  buccal.  The 
cervicofacial consists of marginal mandibular and cervical branches.  The trunks divide 
distally within the superficial lobe to their respective territories on the face and neck.
The parotid region contains the following compartments.
Superficial (or) the nerve compartment contains
• Greater auricular nerve
• Auriculo temporal nerve
• Facial nerve
Middle compartment contains
• Superficial temporal vein.
• Internal maxillary vein.
• Anterior and posterior branches of the posterior facial vein.
• Posterior auricular vein.
• External jugular vein.
Deep compartment contains
• External carotid artery
• Internal carotid artery
• Superficial temporal artery
 Parotid gland innervations
Via the Auirculotemporal nerve.
Sensory innervations are from the Trigeminal nerve, having cell of origin in the 
Trigeminal ganglion.
Parasympathetic Innervations
Is  from the Glossopharyngeal  nerve.   The postganglionic  parasympathetic  cell 
bodies are located in the inferior salivary nucleus in the medulla oblongata.
  
The preganglionic parasympathetic (Jacobson’s) branch originates in the jugular 
fossa.  The fibers leave the tympanic plexus by way of the lesser petrosal nerve, leave 
the skull through the foramen ovale or its own bony canal and terminates in the Otic 
ganglion.  Para sympathetic fibers from CN VII may reach the otic ganglion via the 
chorda tympani nerve and anastomose between CN IX and CN II. 
Sympathetic innervation
Is from the superior sympathetic ganglion and reaches the parotid via the external 
carotid plexus and its branches.
The  parotid  gland  is  associated  with  a  rich  network  of  lymphatics.  During 
embryogenesis, the parotid anlage is the first to develop but it becomes encapsulated 
after  submandibular  and sublingual  gland.   This  delayed encapsulation is significant 
because it results in entrapment of the lymph nodes.  In addition, during encapsulation of 
the intra parotid and periparotid lymphnodes, salivary epithelial cells can be included 
within these nodes.  It is this special embryogenesis of the parotid gland that is believed 
to play a role in the development of Warthin’s tumours and possibly lymphoepithelial 
cysts.
The  pre  auricular  and  infra  auricular  lymph nodes  constitute  the  para  parotid 
(superficial to the capsule of the gland) group, which drain the temporal region of the 
scalp and auricle, the intraparotid (intra-parenchymal) node receives lymphatics from 
the  posterior  nasopharynx,  soft  palate  and  the  ear.  Hyperplasic  or  neoplastic 
involvement of these nodes may manifest as parotid mass.
Parotido massetric fascia:  
- Covers the muscle and splits to invest the parotid gland.
- Attaches to the zygomatic arch superiorly.
- Continues  inferiorly  as  the  investing  cervical  fascia  over  the  sternocleidomastoid 
muscle.
Is fused with the dense and tough superficial fascia covering the gland. Sends 
many irregular septae into the gland, making many compartments within it. Unlike the 
submandibular gland, the parotid gland cannot be easily separated from its connective 
tissue, capsular bed.
Extends deep to the posterior border of the ramus of the mandible, where it fuses 
with  fascia  of  the  posterior  belly  of  digastric  muscle  into  a  strong  band  called 
stylomandibular ligament.
Attaches  inferiorly  to  the  lower  border  of  the  mandible,  investing  the  entire 
masseter muscle except at its deep upper portion. Here, there is a communication with 
the facial planes associated with the insertion of the temporalis muscle.
The Parapharyngeal space
Understanding the anatomy of the parapharyngeal space is crucial for removal of 
the deep lobe parotid tumour.  If the parapharyngeal space is assumed to be pyramidal in 
shape, the base being the base of skull, the apex at the greater cornu of the hyoid bone, 
the medial border is the muscular pharyngeal wall and the lateral border is the medial 
pterygoid muscle and the mandibular ramus.
The normal contents are,
1. The internal carotid artery
2. The ascending pharyngeal artery
3. The pharyngeal venous plexus.
  
The deep lobe parotid tumours will extend into the space by growing in between 
the  stylomandibular  ligament  and  the  bony  mandible  taking  the  pathway  of  least 
resistance.
The Parapharyngeal space is divided into pre and post styloid compartments by an 
imaginary line, which is best appreciated on CT scan drawn from the styloid process on 
to the medial pterygoid plate. Pre operative delineation of the growth characteristics and 
extension of the tumour within the parapharyngeal space by axial imaging may provide 
clues to the pathology of the tumour.
Theory for the Histogenesis
1. Multi cellular theory:
The  genesis  of  neoplasm  from  their  adult  differentiated  counterparts  of  the 
salivary  gland  unit  (eg)  Acinic  cell  carcinomas  would  originate  from  acinar  cells, 
oncocytic  tumour  from  striated  duct  cells,  squamous  cell  carcinomas  and 
mucoepidermoid  carcinomas  from excretory  duct  cells  and  all  other  adenomas  and 
adenocarcinoma from intercalated duct cells.
2. Bi-cellular theory of origin:
Neoplasms develop from the two undifferentiated reserve cells called excretory 
duct reserve cell and the intercalated duct reserve cell.  This theory is more plausible 
because it does not require dedifferentiation duct of cells.
Benign salivary gland neoplasms:
Benign salivary gland neoplasms represent  a  diverse  group of neoplasms with 
varied clinical behaviours.
ETIOLOGICAL FACTORS
1. Radiation
2. Smoking – Warthins tumour.
3. EB virus – increased risk
4. Silica dust
5. Genetic factors (most translocations)
6. Other factors
Most common structural re-arrangement in salivary gland malignancies involving
 Chromosomes: 
(a) Allelic loss of chromosomal arm 12q in pleomorphic adenoma.
(b)Translocation break point at 12q and 15 in pleomorphic adenoma.
WHO – Histological classification of salivary gland tumours
WHO
Class
Tumour
1 Adenoma
1.1 Pleomorphic adenoma
1.2 Myoepithelioma
1.3 Basal cell adenoma
1.4 Warthin’s tumour (adenolymphoma)
1.5 Oncocytoma (oncocytic adenoma)
1.6 Canalicular adenoma
1.7 Sebaceous adenoma
1.8 Ductal papilloma
1.8.1 Inverted ductal papilloma
1.8.2 Intraductal papilloma
1.8.3 Sialadenoma papilliferum
1.9 Cystadenoma
1.9.1 Papillary cystadenoma
1.9.2 Mucinous cystadenoma
2 Carcinoma
2.1 Acinar cell carcinoma
2.2 Mucoepidermoid carcinoma
2.3 Adenoid cystic carcinoma
2.4 Polymorphous  low-grade 
adenocarcinoma
(Terminal duct adenocarcinoma)
2.5 Epithelial-myoepithelial carcinoma
2.6 Basal cell adenocarcinoma
2.7 Sebaceous carcinoma
2.8 Papillary cystadenocarcinoma
2.9 Mucinous adenocarcinoma
2.10 Oncocytic carcinoma
2.11 Salivary duct carcinoma
2.12 Adenocarcinoma
2.13 Malignant myoepithelioma (myoepithelial carcinoma)
2.14 Carcinoma in pleomorphic adenoma (malignant
 
Mixed tumour)
2.15 Squamous cell carcinoma
2.16 Small cell carcinoma
2.17 Undifferentiated carcinoma
2.18 Other carcinomas
3 Non-epithelial tumours
3.1 Angiomas
3.2 Lipomas
3.3 Neural tumours
3.4 Other benign mesenchymal tumours
3.5 Sarcomas
4 Malignant lymphomas
5 Secondary tumours
6 Unclassified tumours
7 Tumour-like lesions
History and physical examination
A  careful  history  and  physical  examination  is  the  first  step  to  differentiate 
between benign and malignant  tumours of the parotid gland.   Benign neoplasms are 
painless, slow growing.  Benign tumours are freely mobile and have no associated nerve 
paralysis or overlying ulceration (Fig.5&6).
A facial nerve paralysis is generally associated with a malignant tumour.  Features 
of malignancy include facial nerve paralysis (or) paresis, pain, and fixation of the mass 
to overlying skin or underlying structures and associated cervical adenopathy.  
Metastatic disease to parotid from skin malignancy should be ruled out by careful 
examination of skin of scalp and face.  The oropharynx should be examined carefully to 
rule out deep lobe involvement. 
A mass in deep lobe of parotid gland or a tumour originating from minor salivary 
gland in the parapharyngeal space may displace soft palate or tonsils medially.
Fine Needle Aspiration cytology
Fine needle aspiration cytology examination in salivary gland tumour was first 
reported by ENEROTH in 1976.  The accuracy of the fine needle aspiration cytology in 
the diagnosis of salivary tumour is well established.  The most common diagnostic error 
is inadequate sampling. FNAC is simple, safe to perform and inexpensive.  FNAC also 
allows pre-operative counseling of patients.  The reported sensitivity ranges from 85% 
to 99% and specificity 100%.  Thus FNAC is helpful in treatment planning for patients 
presenting with salivary gland masses.
CT guided FNAC is most valuable for deep lobe tumours which are likely to be 
malignant and difficult to do biopsy by other methods.
Incisional biopsy
Open biopsy is avoided, because of nerve injury, tumour spillage and associated 
infection and tumour recurrence except in,
1. Doubtful malignancy (in FNAC report) and by clinical examination.
2. Minor salivary gland tumours.  As they are surface tumours, there is no risk of 
implantation.
3. Diffuse enlargement of salivary gland.
Ultra sonogram 
Simple, noninvasive, inexpensive.  It can be used to differentiate between solid 
and cystic masses in salivary gland.  Its use is limited by its ability to visualize only 
relatively superficial masses.
Imaging
The routine  use of  imaging in  patients  with small  well-defined masses  of  the 
superficial  lobe  of  the  parotid  gland  is  not  warranted.   CT  and  MRI  give  a  better 
understanding  of  the  location  and  extent  of  the  tumours,  relation  to  neurovascular 
structures,  perineural  spread  of  malignancy,  skull  base  invasion  and  intracranial 
extension (Fig.7).  Nuclear imaging using technetium 99m pertechnate is helpful only in 
patients with oncocytic and Warthin’s tumours.  Bony destruction of the mandible or 
skull base is best visualized on CT. Bone-marrow involvement it is better demonstrated 
on MRI.  Both may adequately evaluate the neck for the metastatic adenopathy.  MRI is 
superior to CT in demonstrating the internal architecture of salivary gland tumours.
Perineural spread may be detected earlier in MRI
Indication for CT scan 
              1. Mass confined to deep lobe of the parotid gland.
              2. Tumours with involvement of both the deep and superficial lobes of 
the parotid gland (dumb bell tumours).
3. Parotid tumour presenting with facial nerve weakness, other neural deficit 
or indication of malignancy 
              4. Congenital parotid masses 
              5. Recurrent disease  
Benign tumours
Pleomorphic adenoma
Pleomorphic  adenomas (benign mixed tumour)  are  the  most  common tumour. 
They contain both epithelial and connective tissue elements.  The current theory is that 
they  originate  from  intercalated  and  myoepithelial  cells.   They  are  painless,  slow 
growing.   About 90% of the tumours originate superficial  to the plane of  the facial 
nerve.  The  remaining  10% originate  in  the  deep  lobe.  Pleomorphic  adenoma  when 
originate in the minor salivary glands, mostly occur in the hard and soft palate.  The 
second most common place of origin is the upper lip.  Unlike most mixed tumours those 
in  the palate  and lip  frequently  lack a  capsule.   Although the parapharyngeal  space 
contains cranial nerves IX to XII, these structures are rarely involved. 
Microscopically  the  tumour  extends  through  the  capsule,  so  that  the  tumour 
should never be enucleated, because of the pseudopodia like extensions of the tumour 
(Fig.8).
Warthin’s tumour or Papillary cystadenomas or Adenolymphoma.
This  amounts  for  10-15%  of  all  parotid  tumours.   This  is  the  second  most 
common type of benign salivary tumour.  It has a striking male preponderance.  Bilateral 
in 10%, commonly has unilateral multifocal involvement.
Embryologically, the parotid gland is the first salivary gland to develop and the 
last  to  become  encapsulated.   One  hypothesis  concerning  Warthin’s  tumours  is  the 
incorporation  of  salivary  ducts  and  lymphatic  tissue  during  their  late  encapsulation. 
Mitochondrial rich oncocytes are found in Warthin’s tumour  and oncocytomas, the only 
other  benign  tumour  with  frequent  bilateral  presentation.   Oncocytes  selectively 
incorporate Tc 99M and appear as hot spots on a radio nucleotide scan.  Most other 
neoplasms either have normal uptake or appear as cold nodules.
Oncocytomas:
They account for less than 1% of salivary tumours. They usually are benign and 
originate from oncocytes.  A true oncocytoma contains no lymphoid tissue.  They have 
abundant  mitochondria.   Although  histologically  benign,  they  have  a  destructive 
potential.
Hemangiomas and vascular malformations
Hemangiomas are usually seen in infants.  A rapid growth phase occurs between 
1-6 months followed by gradual involution over 1 to 12 years.  They are mostly seen in 
females.  Treatment consists of steroids administered at 2 to 4 mg/kg per day.  If the 
hemangioma is responsive to steroids, the result is usually immediate and often 
dramatic. Unfortunately the response rate is 40 – 60%.  In such patients, interferon may 
be useful, but it is reserved for life threatening situations, because of its toxicity and the 
necessity to continue the drug for prolonged periods. Surgical excision or various types 
of laser treatment may be performed for select circumstances.
                                  
                               
Malignant tumours
Mucoepidermoid carcinoma
Mucoepidermoid  carcinoma is  the most  common malignant  tumour  of  parotid 
gland and the second most common neoplasms of parotid.  Mucoepidermoid carcinomas 
contribute 35% of all salivary gland tumours, of which 80 to 90% occur in the parotid 
gland.  It contains two major elements, mucin producing cells and epithelial cells of the 
epidermoid variety  (Fig.9). 
Mucoepidermoid carcinomas are classified into well-differentiated, intermediate 
and poorly differentiated tumours.  
CLODE and others have reported a cumulative survival rate of 47% for patients 
with  low-grade  mucoepidermoid  carcinoma  and  30%  for  those  with  high-grade 
mucoepidemoid carcinoma.
Adenoid cystic carcinoma
Adenoid cystic carcinoma contributes 10% of all salivary neoplasms.  It is the 
second  most  common  malignant  tumour  of  the  salivary  glands.  Adenoid  cystic 
carcinoma  is  the  most  common  malignant  tumour  found  in  the  submandibular, 
sublingual and minor salivary glands.  It is slightly more common in females.
Adenoid cystic carcinoma is described in three histological sub-types based on 
tumour architecture: Cribriform, tubular and solid.  The cribriform pattern has the classic 
“Swiss cheese appearance”, wherein the cells are arranged in nests separated by round or 
oval  spaces.   They  are  merely  extracellular  spaces  lined  by  replicated  basement 
membrane material (Fig.10).
The tubular variety has the best prognosis, the solid variety has the worst and the 
cribriform pattern has an intermediate  prognosis.   Adenoid cystic  carcinoma usually 
exhibits a protracted course characterized by an indolent growth pattern and a relentless 
tendency for local and perineural invasion.  This neurotropic tendency has been reported 
to occur in 20 – 80% of patients. 
           
The pathogenesis of perineural involvement is poorly understood and was thought 
to  be due to  spread of  tumour through perineural  lymphatics.   The most  commonly 
involved nerves are maxillary (V.2) and the terminal branches of trigeminal nerve and 
facial nerve.
Perineural involvement is more frequent in patients with advanced and recurrent 
tumours and in those with high-grade tumours.
Acinic Cell Carcinoma
Acinic cell carcinoma represents 3% of all salivary gland tumours.  The majority 
occurs in parotid gland (80% to 90%) where in they constitute 15% of its malignant 
neoplasms.  Two thirds occur in females, which makes acinic cell carcinoma the second 
most common neoplasm after Warthins tumours, to exhibit bilateral presentation.
Acinic cell carcinoma is generally regarded as a low-grade malignancy. Compared 
with Adenoid cystic carcinoma or mucoepidermoid carcinoma, acinic cell carcinoma has 
a more favourable prognosis.
Malignant mixed tumour
As the name implies, the malignant mixed tumour represents a malignancy with 
epithelial  and mesenchymal elements.   They constitute 3% to 12% of salivary gland 
cancer  and  three-fourths  are  in  parotid  gland.  When  they  arise  from  pre-existing 
pleomorphic  adenoma,  they  are  called  carcinoma  ex-pleomorphic  adenoma.   By 
contrast  de  novo  malignant  mixed  tumour  is  a  true  carcinosarcoma  with  malignant 
features of  the epithelial  and mesenchymal  elements  that  are  present  in  the primary 
tumour and its metastasis.  This rare true malignant mixed tumour is highly lethal.
Lymphomas:
Lymphomas of the salivary glands may originate from intra glandular lymphomas 
(nodal) or from the lymphoid tissue dispersed within the salivary gland parenchyma 
(extra nodal), which is considered as part of MALT system.  Lymphoma can be primary 
or part of disseminated lymphoma.
Approximately 5% of all extra nodal lymphomas affect the salivary gland and 
more  than  90% of  salivary  gland  lymphomas  occur  in  the  parotid  gland.   Most  of 
salivary gland lymphomas are the NHL variety (85%).
Secondary (metastatic tumours)
Hematogenous  metastases  to  salivary  gland  from infraclavicular  primaries  are 
rare.  These are mainly from lungs, kidneys and breast.  The majority of metastasis to 
salivary glands is caused by lymphatic spread from cutaneous malignancy of the head 
and neck. Metastatic tumour accounts for less than 10% of malignant parotid tumours. 
Of these, 40% are squamous cell carcinomas and 40% are melanomas.
TNM STAGING 
TX - Primary tumour cannot be assessed.
T0 - No evidence of primary tumour.
T1 - Tumour 2cm (or) less in greatest dimension without 
extraparenchymal Extension.
T2 - Tumour 2 to 4cm without extra parenchyma extension.
T3 - Tumour > 4cm or with extra parenchymal extension.
T4 (a)- Tumour invades skin, mandible, ear canal, facial nerve or any of 
           these Structures.
T4 (b) - Tumour invades skull base (or) pterygoid plates (or) encases carotid 
                     artery.
N (Regional nodes):
Nx -  Regional lymph nodes cannot be assessed.
N0 - No regional lymph node metastasis.
N1 - Metastasis in a single ipsilateral lymph node < 3cm.
N2a - Metastasis in a single ipsilateral lymph node 3 to 6cm.
N2b - Metastasis in a multiple ipsilateral lymph node < 6cm.
N2c - Metastasis in bilateral (or) contra lateral lymph node < 6cm.
N3 - Metastasis in a lymph node > 6cm.
Distant Metastasis (M)
Mx -  Distant metastasis cannot be assessed.
M0 - No distant metastasis.
M1 - Distant metastasis.
Staging
I - T1N0M0
T2N0M0
II - T3N0M0
III - T1N1M0
T2N1M0
IV - T4N0M0
T3N1M0
ANYT, N2M0
ANYT, N3M0
ANYT, ANYN, M1
                                                      
Treatment
The treatment of benign tumours has passed through several phases during the last 
30 years.  Surgery is the treatment of choice for all. 
Benign tumours
Small,  localized  tumours  of  the  superficial  lobe  are  treated  adequately  by 
superficial  conservative  Parotidectomy  (Fig.11,12$13).  Large  tumours  and  tumours 
involving  deep  lobe  and  dump  bell  tumours  require  total  parotidectomy  with 
preservation of facial nerve.
Malignant tumours
Total  conservative  Parotidectomy  with  postoperative  radiotherapy  is  the 
treatment.  If the facial nerve is directly involved by the tumour or if the course of the 
nerve interferes with the complete removal of the gland then the nerve is sacrificed and 
primary nerve graft with greater auricular nerve is done, if this fails then later attempts 
to  rehabilitate  the  facial  nerve  is  done  with  cross-face  anastomosis  technique  or 
faciohypoglossal anastomosis.
Rarely, radical  excision of parotid gland with sacrifice of the facial nerve and 
attached  muscles,  mandible  and  temporal  bone  can  be  done.   If  cervical  nodes  are 
involved  then  modified  radical  neck  dissection  is  indicated.   If  local  recurrence  is 
anticipated  because  of  histologically  positive  margin  or  if  tumor  is  high  grade  or 
advanced stage of the tumour, then postoperative radiotherapy is used.
Intra operative variation
From the onset, the anesthesiologist should avoid the use of paralytics or muscle 
relaxants.  This is done so that either EMG monitoring of facial musculature or nerve 
localization by electro stimulation is permitted during the operation.  The use of intra 
operative facial  nerve monitoring through the use  of  nerve integrity  monitor  can be 
done.  It was proposed informally as early as 1991. 
Hemostasis is improved with use of bipolar cautery in areas adjacent to the facial 
nerve to help reduce thermal injury to nerve.  Recently the Shaw scalpel has been used 
in  parotidectomy  to  reduce  blood  loss.   The  Shaw  scalpel  is  a  thermally  activated 
scalpel, popularly known as Bipolar scissors with saline irrigation for faster dissection in 
a relatively bloodless field.  Harmonic scalpel can be used for the same purposes.  The 
generator of the unit transmits ultrasonic energy at the tip of the scalpel. Simultaneous 
sharp dissection and hemostasis are obtained by the ultrasonic energy, which works by 
denaturing the protein molecules.  Because there is no heat production, it is quite safe to 
direct  tissues  with  the  harmonic  scalpel  in  close  proximity  to  nerves  or  other  vital 
structures.
Complications of surgery
EARLY
1. Facial nerve neuropraxia
2. Facial nerve injury
3. Hemorrhage
4. Sialocele
5. Flap necrosis
6. Salivary fistula
7. Infection
8. Otitis externa
LATE
    
Frey’s syndrome
 
FREY’S SYNDROME
It  is  the  occurrence  of  redness  and  sweating  in  the  area  of  distribution  of 
Auriculotemporal  nerve,  when eating,  which is  seen in  patients  after  parotidectomy. 
The true incidence is unknown but is estimated to be between 35% - 60%.  This is 
caused  by  regeneration  of  secretory  fibers  of  parotid  gland  contained  in 
auriculotemporal  nerve,  to  sweat  glands  in  its  area  of  distribution.   Thus  the  sweat 
glands respond to the nerve impulses that would reflexly provoke parotid secretion.  The 
diagnosis of Frey’s syndrome depends on patient’s symptoms. An objective method of 
confirming the diagnosis is the miner’s starch and iodine test.
Most patients with Frey’s symptoms require nothing more than education and Re-
assurance.  The application of topical glycopyrrolate (or) mild anti-perspirant is a simple 
and effective approach. It can be also relieved by section of the glossopharyngeal nerve, 
which supplies the pre-ganglionic fibers for the parotid gland. 
Radiotherapy
The indication and technique of radiotherapy to be used as well as the response of 
salivary gland tumours to treatment depends upon the location of the primary lesion as 
well as extent and histological make out.
It is used as 
Curative – as an adjunct to surgery.
Palliative –
 - Inoperable tumours.
- For recurrent lesions.
- Symptomatic treatment of distant metastasis. 
The indications for adjuvant radiotherapy to tumour bed are
1. For all cases of adenoid cystic carcinoma.
2. High-grade tumours.
3. Positive margins.
4. Nodal metastasis.
5. Advanced stage (stage III & IV)
 Since skip metastasis are possible, entire neck is to be irradiated.  It is used in 
doses of 6000-6500 rads in fractionated doses for 6-7 weeks.
Complications of Radiotherapy
1. Ageusia
2.  Diminished salivation
3. Mucosal necrosis
4. Trismus
5. Caries tooth
6. Osteonecrosis
Chemotherapy
It  is  used  as  a  palliative  treatment  for  recurrent  or  metastatic  salivary  gland 
malignant neoplasm. Single drug therapy is commonly used with one of the following 
drugs – Doxorubicin, 5FU, Methotrexate, cyclophosphamide or cisplatin.
Combination chemotherapy can also be used. Regimens include:
CAP (Cyclophosphamide, Adriamycin, Cisplatin) 
FACP (5FU, Adriamycin, Cyclophosphamide and Cisplatin)
Management of facial nerve paralysis.
1. Neurotherapy
2. Inter position of nerve graft.
3. Cross-over re-innervation procedures.
- Hypoglossal
- Cross facial
- Ansa hypoglossi
Regional muscle transfer
- Temporalis
- Digastric
- Massetric
Micro-neuro vascular free flap
- Gracillis
- Rectus abdominis
- Pectoralis minor
- Latissimus dorsi
- Serratus anterior
- Extensor digitorum brevis.
Static re-animation and cosmetic procedure
1. Eyelid procedures
- Spring 
- Gold weights
-Lower lid tightening
2. Brow and forehead lift.
3. Correction of mid facial deformity
 - Fascia lata slings
 - Alloplastic sheets.
 - Malar augmentation.
 4.  Face lift operation.
5. Lower lip wedge resection.
6. Botulinium toxin.
AIMS AND OBJECTIVES
• To analyse the epidemiology of parotid tumours 
• To analyse the various presentation of parotid tumours.
• To find out risk factors.
• To discuss the role of FNAC in the management of parotid tumours.
• To discuss various treatment modalities of parotid tumours.
• To analyse the frequency of facial nerve involvement by the tumour.
• To analyse the facial nerve injuries after surgery.
• To analyse the post operative complications
MATERIALS AND METHODS
Patient  admitted  between May 2006 to  November  2008 (3 years).  They were 
randomly  selected  (total  42)  and assessed  by  FNAC pre  operatively  and proven by 
Histopathological examination post operatively.
In all cases a thorough clinical history and physical examination were carried out 
age, sex and risk factors if any were noted down.
Basic investigations were done for all patients’. CT scan was done in a few cases.
A master  chart  was created and the data entered and analysed.   Based on the 
investigations,  cases  were  divided  into  benign  and  malignant  neoplasms  and  were 
treated appropriately.
Follow up was done in our outpatient facility.  Patients were referred for 
postoperative radiotherapy and readmitted if any complications arose.
                                        OBSERVATION AND DISCUSSION
This study included Parotid  tumours in  THANJAVUR MEDICAL COLLEGE 
from May 2006 to November 2008.
Patients were analysed both retrospectively and prospectively. All tumours were 
histological proved.
A total of 42 cases of Parotid tumours were randomly studied. Of these 29 Proved 
to be benign tumours. 13 proved to be malignant. The benign and malignant neoplasms 
are considered separately and discussed with the help of available literature.
   
Our study Other studies
Eweson & Cawsons et al
Malignant (%)
Benign (%)
13 (31%)
29 (69 %)
 15%
72%
DISCUSSION
Benign tumours
Each were categorized into sex,  age,  presenting symptoms, type of Pathology, 
type of lobe involved, treatment given and post operative complications.  
1. Sex:
In  this  study  benign  parotid  tumours  9  patients  were  male,  20  patients  were 
female.
Sex No. Of patients %
Male 9 31%
Female 20 69%
In this study benign tumours were more among females. Male female ratio was 
1:2.2
  
2. Age:
In this study commonest age group affected was 31-40 years, the oldest patient 
was 70-year-old female and youngest patient was 4 years female.
Age No.  Of 
patients
%
1-10 1 3.44%
11-20 3 10.34%
21-30 7 24.13%
31-40 10 34.48%
41-50 2 6.89% 
  >50 6 20.68%
3. Lobes involved
In our study 28 patients were superficial lobe only involved.  1 patient was both 
Superficial and deep lobe involved.
Lobes involved No. Of patients %
Superficial lobe 28 96.55
Deep & superficial lobe 1 3.45
4. Risk factors:
The commonest risk factors are smoking tobacco chewing and betalnut chewing.
Habits No. Of patients    %
Smoking 4 13.80
Tobacco chewing 3 10.34
Betalnut chewing 4 13.80
Alcohol and smoking 3 10.34
Tobacco  chewing  & 
smoking
2 6.90
  
5. Clinical presentation:
In this study the benign tumours commonly presented as a painless swelling.
Symptoms No. Of patients %
Painless swelling
Swelling & pain
Recurrent swelling
21
7
1
72.41
24.13
3.44
6. Pathology:
In this study, most common benign of parotid gland tumours were pleomorphic 
Adenoma.
One patient reported as hamartoma
Pathology No. Of patients %
Pleomorphic 
adenoma
24 82.75
Monomorphic 
adenoma
4 13.80
Hamartoma 1 3.44
7. Investigation:
In this study the following investigations were done for all patients who include 
Blood urea, serum creatinine, blood sugar, x-ray chest, and FNAC, CT scan neck was 
done in few selected cases.
In this study, FNAC was easy investigation with virtually no complication.  It is a 
non-expensive,  reliable  and  repeatable  simple  investigation.   In  our  study  FNAC 
findings confirmed by postoperative histopathological examination.
The sensitivity and specificity of FNAC
FNAC was the key investigation done in all cases. It provided accurate diagnosis 
in most parotid tumours and contributed to conservative management.
  
                                                True positive
        Sensitivity =      ------------------------------------       
                                      True positive + false negative         
.                                                  True negative
        Specificity =        ----------------------------------------
                                        True negative + false positive        
No. Of patients True (+) False 
(+)
Sensitivity Specificity
29 28 1 96.5 100%
In our study, the sensitivity of FNAC in benign parotid tumour was 96.5%
Specificity 100%.
8. Types of surgery:
In this study all cases of benign parotid neoplasms of superficial lobe were treated 
by  superficial  conservative  Parotidectomy.  One patient  underwent  total  conservative 
Parotidectomy due to involvement of both lobes.
Surgery done No. Of patients %
Superficial  conservative 
parotidectomy
28 96.55
Total  conservative 
parotidectomy
1 3.45
For one patient pre operative FNAC was pleomorphic adenoma and CT was done 
because clinically  deep lobe was involved.  The patient  underwent  total  conservative 
Parotidectomy. 
9. Post operative complications:
The postoperative period was uneventful in most of the cases. Uneventful 
Patients were discharged on the 7th postoperative day after suture removal.
          Neuropraxia developed in 3 cases i.e. 10.3%, managed conservatively. 
Full recovery was there. 
          Wound infection developed in 5 cases, were treated with appropriate antibiotics.
S.No Post  operative 
complication
No. Of patients %
1. Wound infection 4 13.80
2. Facial nerve palsy 2 6.90
3. Wound infection with facial 
palsy
1 3.45
4. Uneventful 22 75.86
                                                  
MALIGNANT TUMOURS
Out  of  42  patients,  13  patients  were  affected  with  malignant  parotid  gland 
tumours. 
1. Sex:
In our study, 8 patient were female 5 patient were male.
Sex No. Of patients Percentage
Male 5 38.46
Female 8 61.54
2. Age:
In our study commonest age group affected was 5th 6th 7th decades. 
The youngest patient was 12 years old male.
Age group No. Of patients
11-20 2
21-30 2
31-40 1
41-50 1
51-60 4
61-70 3
3. Lobe involved:
Most common lobe to be involved in malignant parotid tumour was superficial 
Lobe.  
  Lobe involvement No. Of patients Percentage
Superficial lobe 10 76.92
Superficial  and  Deep 
lobe
3 23.08
4. Clinical Presentation
      In this study, 4 patients presented with painful swelling, 2 patients presented with 
Facial nerve palsy
 
Symptoms No.  Of 
patients
Percentage
Painless swelling 7 53.85
Swelling with pain 4 30.76
Swelling with facial nerve 
palsy
2 15.38
5. Pathology:
In  our  study,  13  patients  were  malignant  tumours;  of  these  Mucoepidermoid 
carcinoma was commonest pathological type.
S.No Pathological type No.  Of 
patients
Percentage
Mucoepidermoid 
carcinoma
11 84.61
1. Acinic cell carcinoma 1 7.70
2. Squamous  cell 
carcinoma
1 7.70
   
 In 11 patients of mucoepidermoid carcinoma,
                            Low grade    -- 7
                            Intermediate – 2
                            High grade   -- 2
6. Sensitivity and specificity:
No. Of patient True positive False 
negative
Sensitivity
13 10 3 76.92%
In our  study sensitivity  of  the malignant  parotid  tumour  was  77%, specificity 
100%
7. Staging of the disease:
Stage No. Of patients
  I 2
  II 6
  III 1
  IV 4
Two  patients  initially  presented  with  facial  nerve  palsy,  one  patient  with  skin 
Involvement (ulceration).
8. Treatment:
In  our  study,  out  of  13  patients,  11  patients  underwent  conservative 
Parotidectomy, 1 patient underwent total radical parotidectomy, five patients underwent 
Adjuvant radiotherapy because of high-grade malignancy.
Two  patients  (high  grade  malignancy)  did  not  receive  Adjuvant  radiotherapy 
because  they  lost  follow  up.  One  patient  received  radiotherapy  alone  due  to 
inoperability.
Mode of treatment No.  Of 
patients
Percentage
Superficial  conservative 
Parotidectomy
10      76.93
Total conservative Parotidectomy 1 7.70
Total radical Parotidectomy 1 7.70
Radiotherapy only 1 7.70
Adjuvant Radiotherapy 5 38.46
9. Post operative complications:  
One  patient  developed  neuropraxia,  managed  conservatively.  Resolved 
Spontaneously.
Three patients developed nerve palsy; they were treated by lateral tarsorrhaphy 
and Physiotherapy. Since patient was not willing for flap cover.
Two patients developed wound infection. They were treated with antibiotics.
      Complications No.  Of 
patients
Percentage
Wound infection 1 7.70
Facial nerve palsy 3 23.07
Wound  infection  with  facial  nerve 
palsy
1 7.70
Uneventful 8 61.5
                                                      
CONCLUSION
The clinicopathological study on parotid tumours among the patients admitted at 
Thanjavur medical college hospital showed following facts 
 
 The age incidence for  benign tumour was commonly between 3rd and     4th 
decade. The malignant tumour commonly occurred in 6th and 7th       Decades.
 The sex incidence in both benign and malignant tumours was predominantly in 
females.
 In parotid gland tumours 69 % were benign, 31 % were malignant.
  Pleomorphic adenoma was the commonest benign tumour.
 Mucoepidermoid carcinoma was the commonest malignant tumour.
 In benign tumours, sensitivity and specificity of FNAC were 96.5% and 100% 
respectively.
 In malignant tumours, sensitivity and specificity of FNAC were 77% and     100% 
respectively.
 There were no significant risk factors associated with parotid tumours.
 Commonest clinical presentation in benign and malignant tumours was Painless 
swelling. Swelling associated with facial nerve palsy noted in 15% of Malignant 
Parotid tumours.
 Commonly performed surgery in benign and malignant tumours was Superficial 
Conservative Parotidectomy.
 Adjuvant  radiotherapy  was  given  in  high-grade  tumours  and  acinic  cell 
Carcinoma. 
 In  benign  tumours,  facial  nerve  palsy  occurred  in  10%  of  patients  and  post 
operatively this recovered within 6 weeks; wound infection for 14% of Patients 
and 76% of patients were uneventful.
 In malignant tumours facial nerve palsy occurred post operatively in 30%, treated 
with lateral tarsorrhaphy with physiotherapy.
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